Titanium dioxide nanoparticles induce emphysema‐like lung injury in mice

Titanium dioxide nanoparticles (nanoTiO2) have been widely used as a photocatalyst in air and water cleaning. However, these nanoparticles inhalation can induce pulmonary toxicity and its mechanism is not fully understood. In this study we investigated the pulmonary toxicity of nanoTiO2 and its molecular pathogenesis. The adult male ICR mice were exposed to intratracheal single dose of 0.1 or 0.5 mg nanoTiO2 (19–21 nm) and lung tissues were collected at 3rd day, 1st wk, and 2nd wk for morphometric, microarray gene expression, and pathway analyses. NanoTiO2 can induce pulmonary emphysema, macrophages accumulation, extensive disruption of alveolar septa, type II pneumocyte hyperplasia, and epithelial cell apoptosis. NanoTiO2 induced differential expression of hundreds of genes include activation of pathways involved in cell cycle, apoptosis, chemokines, and complement cascades. In particular, nanoTiO2 up‐regulates placenta growth factor (PlGF) and other chemokines (CXCL1, CXCL5, and CCL3) expressions that may cause pulmonary emphysema and alveolar epithelial cell apoptosis. Cultured human THP‐1 cell‐derived macrophages treated with nanoTiO2 in vitro also resulted in up‐regulations of PlGF, CXCL1, CXCL5, and CCL3. These results indicated that nanoTiO2 can induce severe pulmonary emphysema, which may be caused by activation of PlGF and related inflammatory pathways.—Chen, H‐W., Su, S‐F., Chien, C‐T., Lin, W‐H., Yu, S‐L., Chou, C‐C., Chen, J. J. W., Yang, P. C. Titanium dioxide nanoparticles induce emphysema‐like lung injury in mice. FASEB J. 20, E1732–E1741 (2006)

[1]  S. Akira,et al.  Induction of CXCL5 during inflammation in the rodent lung involves activation of alveolar epithelium. , 2005, American journal of respiratory cell and molecular biology.

[2]  S. Kingsmore,et al.  Protein Microarray Analysis of Disease Activity in Pediatric Inflammatory Bowel Disease Demonstrates Elevated Serum PLGF, IL-7, TGF-β1, and IL-12p40 Levels in Crohn's Disease and Ulcerative Colitis Patients in Remission versus Active Disease , 2005, The American Journal of Gastroenterology.

[3]  J. Finkelstein,et al.  Acute pulmonary effects of ultrafine particles in rats and mice. , 2000, Research report.

[4]  Jeremy J. W. Chen,et al.  Global expression profiling of theophylline response genes in macrophages: evidence of airway anti-inflammatory regulation , 2005, Respiratory research.

[5]  T. Meng,et al.  Removal of natural organic matter from water using a nano-structured photocatalyst coupled with filtration membrane. , 2004, Water science and technology : a journal of the International Association on Water Pollution Research.

[6]  E. Brambilla,et al.  In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[7]  G. Oberdorster,et al.  Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. , 1996, Inhalation toxicology.

[8]  F. Hsieh,et al.  Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema. , 2004, American journal of respiratory and critical care medicine.

[9]  Harald F Krug,et al.  Biological effects of ultrafine model particles in human macrophages and epithelial cells in mono- and co-culture. , 2004, International journal of hygiene and environmental health.

[10]  Gianmario Martra,et al.  The surface area rather than the surface coating determines the acute inflammatory response after instillation of fine and ultrafine TiO2 in the rat. , 2002, International journal of hygiene and environmental health.

[11]  N. Anthonisen,et al.  Chronic obstructive pulmonary disease (COPD). , 1998, American journal of respiratory and critical care medicine.

[12]  Sung-Liang Yu,et al.  Transcriptome analysis in blastocyst hatching by cDNA microarray. , 2005, Human reproduction.

[13]  M. van Buchem,et al.  Involvement of the complement system in the pathogenesis of pulmonary leukostasis in experimental myelocytic leukemia. , 1993, Leukemia.

[14]  T. Standiford,et al.  Macrophage inflammatory protein 1alpha/CCL3 is required for clearance of an acute Klebsiella pneumoniae pulmonary infection. , 2001, Infection and immunity.

[15]  L. Yahia,et al.  Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticles. , 2004, Biomaterials.

[16]  R. Hunter,et al.  Requisite Role for Complement C5 and the C5a Receptor in Granulomatous Response to Mycobacterial Glycolipid Trehalose 6,6′‐Dimycolate , 2005, Scandinavian journal of immunology.

[17]  P Zabel,et al.  [Chronic obstructive pulmonary disease (COPD)]. , 2006, Der Internist.

[18]  C. Auffray,et al.  The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. , 1996, Genomics.

[19]  C. Aaron,et al.  Quantitative morphometric analysis of pulmonary deposition of aerosol particles inhaled via intratracheal nebulization, intratracheal instillation or nose‐only inhalation in rats , 1998, Journal of applied toxicology : JAT.

[20]  B. Morgan,et al.  Physiology and pathophysiology of complement: progress and trends. , 1995, Critical reviews in clinical laboratory sciences.

[21]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[22]  H. van Loveren,et al.  Diesel exhaust particles induced release of interleukin 6 and 8 by (primed) human bronchial epithelial cells (BEAS 2B) in vitro. , 1997, Experimental lung research.

[23]  Jeremy J. W. Chen,et al.  Differential gene expression in gram-negative and gram-positive sepsis. , 2004, American journal of respiratory and critical care medicine.

[24]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  Morgan Bp.  Physiology and Pathophysiology of Complement: Progress and Trends , 1995 .

[26]  Wolfgang Kreyling,et al.  Toxicological hazards of inhaled nanoparticles--potential implications for drug delivery. , 2004, Journal of nanoscience and nanotechnology.

[27]  W. Thurlbeck.  Measurement of pulmonary emphysema. , 1967, The American review of respiratory disease.

[28]  A. Luttun,et al.  Loss of placental growth factor protects mice against vascular permeability in pathological conditions. , 2002, Biochemical and biophysical research communications.

[29]  J. Hogg,et al.  Pathophysiology of airflow limitation in chronic obstructive pulmonary disease , 2004, The Lancet.

[30]  K. Larsson,et al.  COPD diagnosis related to different guidelines and spirometry techniques , 2007, Respiratory research.

[31]  J. Walrath,et al.  Resident Th1-like effector memory cells in pulmonary recall responses to Mycobacterium tuberculosis. , 2005, American journal of respiratory cell and molecular biology.

[32]  C James Kirkpatrick,et al.  Effects of nano-scaled particles on endothelial cell function in vitro: Studies on viability, proliferation and inflammation , 2004, Journal of materials science. Materials in medicine.

[33]  M. Cullen.  Screening for chronic beryllium disease: one hurdle down, two to go. , 2005, American journal of respiratory and critical care medicine.

[34]  Susumu Goto,et al.  The KEGG databases at GenomeNet , 2002, Nucleic Acids Res..

[35]  J. J. Chen,et al.  Dynamic changes of gene expression profiles during postnatal development of the heart in mice , 2004, Heart.

[36]  J. Lasky,et al.  Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. , 1999, The American journal of pathology.

[37]  S. Young,et al.  Transcriptional Profiling of Lipopolysaccharide-Induced Acute Lung Injury , 2004, Infection and Immunity.

[38]  P. Carmeliet,et al.  A critical role of placental growth factor in the induction of inflammation and edema formation. , 2003, Blood.

[39]  E. C. Pearson,et al.  Use of light microscopic immunotechniques in selecting preparation conditions and immunoprobes for ultrastructural immunolabelling of lactoferrin , 1988, The Histochemical Journal.

[40]  A. Luttun,et al.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 , 2002, Nature Medicine.

[41]  Gregory P Cosgrove,et al.  Emphysema lung tissue gene expression profiling. , 2004, American journal of respiratory cell and molecular biology.

[42]  P. Barnes,et al.  New concepts in chronic obstructive pulmonary disease. , 2003, Annual review of medicine.

[43]  Yi-Chen Lin,et al.  Tumor-associated macrophages: the double-edged sword in cancer progression. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  R. Takigiku,et al.  Macrophage inflammatory proteins 1 and 2: expression by rat alveolar macrophages, fibroblasts, and epithelial cells and in rat lung after mineral dust exposure. , 1993, American journal of respiratory cell and molecular biology.

[45]  N. Perelman,et al.  Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. , 2003, Blood.

[46]  M. Burdick,et al.  CXCR2 is critical for dsRNA-induced lung injury: relevance to viral lung infection , 2005, Journal of Inflammation.

[47]  N. Perelman,et al.  Placenta growth factor activates monocytes and correlates with sickle cell disease severity. , 2003, Blood.

[48]  Thurlbeck Wm.  Measurement of pulmonary emphysema. , 1967 .

[49]  J. James,et al.  Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[50]  F. Afaq,et al.  Cytotoxicity, pro‐oxidant effects and antioxidant depletion in rat lung alveolar macrophages exposed to ultrafine titanium dioxide , 1998, Journal of applied toxicology : JAT.